11th International Workshop on Pharmacology of Tuberculosis Drugs
We are pleased to announce the 11th edition of the International Workshop on Clinical Pharmacology of Tuberculosis Drugs which is scheduled for 23 October 2018 in The Hague, Netherlands.
The treatment of Tuberculosis is increasingly becoming a challenge worldwide. All around the world experts in the field are involved in intensive research to be able to cope with the various concerns with regard to treatment.
The aim of this abstract-driven workshop is to make a significant contribution to the optimization of TB treatment, by bringing experts together and having them present and discuss the latest important scientific findings in the TB clinical pharmacology field. Additionally, scientific, regulatory or strategy issues that are highly relevant to the optimization of TB treatment will be exchanged and discussed.
The format of the meeting will be a one-day workshop consisting of invited lectures, abstract presentations and roundtable discussions. Much time will be allocated to questions, answers and discussion in order to set up an intimate interactive workshop.
Topics that will be addressed include pharmacokinetics and pharmacodynamics of new TB drugs, Pharmacokinetics and pharmacodynamics of approved TB drugs, Pharmacokinetic – pharmacodynamic modeling, Drug-drug and drug-disease internactions, New TB drug development tools, new developments in pediatric TB, interactions between TB and HIV drugs, and treatment of MDR- and XDR-TB.
The target audience of this meeting consists of clinical pharmacologists, pharmacists, industry researchers, ID doctors, pediatricians, microbiologists, government representatives and other experts with an interest in clinical pharmacology.
We invite you to attend the 11th International Workshop on Clinical Pharmacology of Tuberculosis Drugs and encourage you to submit abstracts on your research in this field.
The Organizing Committee